This is a preview of subscription content, log in via an institution to check access.
Notes
The six-centre prospective registry, designed to study the natural history of fibrotic ILD in a Canadian population, is funded by Boehringer Ingelheim.
Reference
Algamdi M, et al. Costs of Workplace Productivity Loss in Patients with Fibrotic Interstitial Lung Disease. Chest : 30 Apr 2019. Available from: URL: http://doi.org/10.1016/j.chest.2019.04.016
Rights and permissions
About this article
Cite this article
Substantial societal burden of fibrotic interstitial lung disease. PharmacoEcon Outcomes News 828, 31 (2019). https://doi.org/10.1007/s40274-019-5905-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5905-7